🇺🇸
United States · US · US:71288-144_77b41d41-9975-428a-865a-1593d21b3d99
Docetaxel anhydrous
In shortageOrange BookUNIISPLATC L01CD02
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerMeitheal Pharmaceuticals Inc
CountryUS (United States)
ATC codeL01CD02
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 2
- ndc1171288144081 VIAL, MULTI-DOSE in 1 CARTON (71288-144-08) / 8 mL in 1 VIAL, MULTI-DOSE
- ndc1171288144161 VIAL, MULTI-DOSE in 1 CARTON (71288-144-16) / 16 mL in 1 VIAL, MULTI-DOSE
Annotations
UNII (FDA Substance ID)
699121PHCA
DOCETAXEL ANHYDROUS
RxCUI 1299922
Orange Book
A209634
APAPAP
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Docetaxel Injection
Raw payload (JSON)
{
"unii": {
"unii": "699121PHCA",
"rxcui": "1299922",
"inchikey": "ZDZOTLJHXYCWBA-VCVYQWHSSA-N",
"display_name": "DOCETAXEL ANHYDROUS",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"81686d37-a13f-46e2-b439-a84eb1433634": {
"match": "brand_token",
"title": "DOCETAXEL INJECTION [HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC.]",
"spl_version": "2",
"published_date": "2026-05-13"
}
},
"productid": "71288-144_77b41d41-9975-428a-865a-1593d21b3d99",
"productndc": "71288-144",
"dosage_form": "INJECTION, SOLUTION",
"orange_book": {
"appl_no": "209634",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "20MG/2ML (10MG/ML)",
"product_no": "001",
"approval_date": "Aug 24, 2018"
},
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "80MG/8ML (10MG/ML)",
"product_no": "002",
"approval_date": "Aug 24, 2018"
},
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "160MG/16ML (10MG/ML)",
"product_no": "003",
"approval_date": "Aug 24, 2018"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "DOCETAXEL ANHYDROUS",
"shortage_reason": "Docetaxel Injection",
"shortage_status": "current",
"proprietary_name": "Docetaxel anhydrous",
"active_ingred_unit": "mg/mL",
"application_number": "ANDA209634",
"marketing_category": "ANDA",
"nonproprietary_name": "Docetaxel anhydrous",
"start_marketing_date": "20180824",
"active_numerator_strength": "10"
}Related drugs
Other records sharing ATC code L01CD02.
- BEBaglycacon 10 mg/mlSandoz
- BEBaglycacon 10 mg/mlSandoz
- BEBaglycacon 10 mg/mlSandoz
- 🇺🇸BEIZRAYZydus Pharmaceuticals USA Inc.
- 🇺🇸BEIZRAYZhuhai Beihai Biotech Co., Ltd.
- 🇺🇸BEIZRAYZydus Pharmaceuticals USA Inc.
- 🇺🇸BEIZRAYZhuhai Beihai Biotech Co., Ltd.
- NLDemotaxel Mono 20 mg/ml, concentraat voor oplossing voor infusieDemo S.A. Pharmaceutical Industry
Access this data programmatically
Query Docetaxel anhydrous and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.